Annual EBITDA
-$741.79M$365.63M-97.20%
Summary
- Current Value
- As of today, RNA annual EBITDA is -$741.79M, down -97.20% on
- Historical Performance
- RNA annual EBITDA is down -317.85% over the past 3 years, down -1589.58% over the past 5 years
- All-Time High Comparison
- RNA annual EBITDA is currently -7233.58% below its historical high of -$10.12M set on
- 3-Year Low Comparison
- RNA annual EBITDA is at its 3-year low
- Sector Comparison
- RNA annual EBITDA is higher than 0.85% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$741.79M | -97.2% | -317.9% | -1589.6% | -7233.6% | |
| Quarterly EBITDA | -$252.98M | -110.4% | -378.7% | -1463.7% | -10000.0% | |
| TTM EBITDA | -$741.79M | -97.2% | -317.9% | -1589.6% | -10000.0% | |
| Price | $14.75 | -49.3% | -36.0% | -38.9% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $18.76M | +72.1% | +103.3% | +176.3% | +4848.6% | |
| Annual EPS | -$4.97 | -72.1% | -49.0% | -142.8% | -1562.7% | |
| -$745.94M | -96.8% | -316.9% | -1584.7% | -7005.6% | ||
| Annual Net Income | -$684.63M | -112.4% | -293.5% | -1443.5% | -6004.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$177.53M | N/A | -317.9% |
| 5Y | -$43.90M | N/A | -1589.6% |
| All | -$10.12M | -7233.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$741.79M | at low | |
| 5Y | -$741.79M | at low | |
| All | -$741.79M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$741.79M | -97.2% | |
| -$376.16M | -61.1% | |
| -$233.50M | -31.5% | |
| -$177.53M | -51.2% |
| Year | Value | Change |
|---|---|---|
| -$117.41M | -167.4% | |
| -$43.90M | -162.3% | |
| -$16.74M | -65.4% | |
| -$10.12M | - |
FAQ
What is the current annual EBITDA of RNA?
As of today, RNA annual EBITDA is -$741.79M
What is 1-year change in RNA annual EBITDA?
RNA annual EBITDA is down -97.20% year-over-year
What is 3-year change in RNA annual EBITDA?
RNA annual EBITDA is down -317.85% over the past 3 years
How far is RNA annual EBITDA from its all-time high?
RNA annual EBITDA is currently -7233.58% below its historical high of -$10.12M set on December 31, 2018
How does RNA annual EBITDA rank versus sector peers?
RNA annual EBITDA is higher than 0.85% of companies in Healthcare sector
When is RNA next annual earnings release?
As of today, the next annual earnings release for RNA has not been scheduled
Quarterly EBITDA
-$252.98M$65.23M-34.74%
Summary
- Current Value
- As of today, RNA quarterly EBITDA is -$252.98M, down -34.74% on
- Historical Performance
- RNA quarterly EBITDA is down -110.38% year-over-year, down -378.73% over the past 3 years
- All-Time High Comparison
- RNA quarterly EBITDA is currently -12423.86% below its historical high of -$2.02M set on
- 3-Year Low Comparison
- RNA quarterly EBITDA is at its 3-year low
- Sector Comparison
- RNA quarterly EBITDA is higher than 0.82% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$252.98M | -34.7% | -110.4% | -378.7% | -1463.7% | |
| Annual EBITDA | -$741.79M | – | -97.2% | -317.9% | -1589.6% | |
| TTM EBITDA | -$741.79M | -21.8% | -97.2% | -317.9% | -1589.6% | |
| Price | $14.75 | -79.4% | -49.3% | -36.0% | -38.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $860.00K | -93.1% | -71.1% | -68.9% | -59.9% | |
| Quarterly EPS | -$1.59 | -25.6% | -99.6% | -80.3% | -265.6% | |
| -$254.48M | -34.8% | -110.3% | -378.1% | -1461.9% | ||
| Quarterly Net Income | -$237.10M | -35.9% | -131.9% | -369.8% | -1356.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$120.25M | N/A | -110.4% |
| 3Y | -$51.37M | -392.4% | |
| 5Y | -$16.18M | N/A | -1463.7% |
| All | -$2.02M | >-9999.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$252.98M | at low | |
| 3Y | -$252.98M | at low | |
| 5Y | -$252.98M | at low | |
| All | -$252.98M | at low |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RNA?
As of today, RNA quarterly EBITDA is -$252.98M
What is RNA quarterly EBITDA most recent change?
RNA quarterly EBITDA was down -34.74% on December 31, 2025
What is 1-year change in RNA quarterly EBITDA?
RNA quarterly EBITDA is down -110.38% year-over-year
How far is RNA quarterly EBITDA from its all-time high?
RNA quarterly EBITDA is currently -12423.86% below its historical high of -$2.02M set on March 31, 2019
How does RNA quarterly EBITDA rank versus sector peers?
RNA quarterly EBITDA is higher than 0.82% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
TTM EBITDA
-$741.79M$132.73M-21.79%
Summary
- Current Value
- As of today, RNA TTM EBITDA is -$741.79M, down -21.79% on
- Historical Performance
- RNA TTM EBITDA is down -97.20% year-over-year, down -317.87% over the past 3 years
- All-Time High Comparison
- RNA TTM EBITDA is currently -36622.38% below its historical high of -$2.02M set on
- 3-Year Low Comparison
- RNA TTM EBITDA is at its 3-year low
- Sector Comparison
- RNA TTM EBITDA is higher than 0.82% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$741.79M | -21.8% | -97.2% | -317.9% | -1589.6% | |
| Annual EBITDA | -$741.79M | – | -97.2% | -317.9% | -1589.6% | |
| Quarterly EBITDA | -$252.98M | -34.7% | -110.4% | -378.7% | -1463.7% | |
| Price | $14.75 | -79.4% | -49.3% | -36.0% | -38.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $18.76M | -10.1% | +72.1% | +103.3% | +176.3% | |
| TTM EPS | -$4.96 | -19.0% | -71.2% | -49.2% | -319.3% | |
| -$745.94M | -21.8% | -96.8% | -316.9% | -1584.7% | ||
| TTM Net Income | -$684.63M | -24.5% | -112.4% | -293.5% | -1443.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$376.16M | N/A | -97.2% |
| 3Y | -$177.52M | N/A | -317.9% |
| 5Y | -$43.90M | N/A | -1589.6% |
| All | -$2.02M | >-9999.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$741.79M | at low | |
| 3Y | -$741.79M | at low | |
| 5Y | -$741.79M | at low | |
| All | -$741.79M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RNA?
As of today, RNA TTM EBITDA is -$741.79M
What is RNA TTM EBITDA most recent change?
RNA TTM EBITDA was down -21.79% on December 31, 2025
What is 1-year change in RNA TTM EBITDA?
RNA TTM EBITDA is down -97.20% year-over-year
How far is RNA TTM EBITDA from its all-time high?
RNA TTM EBITDA is currently -36622.38% below its historical high of -$2.02M set on March 31, 2019
How does RNA TTM EBITDA rank versus sector peers?
RNA TTM EBITDA is higher than 0.82% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RNA Official Website www.aviditybiosciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990126000031/0001599901-26-000031-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990126000031/0001599901-26-000031-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna